Paeds Vivas · clinical-pharmacology-and-therapeutics
Renal and hepatic dose adjustment in children — branching viva
Branching viva on bedside Schwartz eGFR and renal dose adjustment, Child-Pugh grading and hepatic dose adjustment, vancomycin therapeutic monitoring, and the transition of estimating equations and doses to adult care.
On this page & tools
Target exams
Station map
Branch A — Renal dose calculation
Examiner: An 8-year-old is 128 cm tall with a serum creatinine of 1.5 mg per dL on a modern enzymatic assay. Calculate the estimated GFR, stage it, and tell me what it means for a renally cleared drug. [1]
Strong answer should include:
- State the bedside Schwartz equation: eGFR equals 0.413 times height in cm divided by serum creatinine in mg per dL, indexed to 1.73 m2. [1]
- Calculate: 0.413 times 128 divided by 1.5, about 35 mL per min per 1.73 m2. [1]
- Stage as KDIGO G3b (30 to 59), and state that most renally cleared drugs need a dose reduction from category G3a (under 60). [4]
- Give the loading dose in full (depends on volume of distribution), then reduce the maintenance dose or extend the interval per the formulary. [5]
Trap: quoting the original 0.55 constant, or forgetting that the loading dose still applies in organ impairment. [1]
Branch B — Cirrhotic child, grade the liver
Examiner: A 10-year-old with biliary atresia has bilirubin 58 micromol per L, albumin 27 g per L, INR 1.9, moderate ascites and grade 1 encephalopathy. Grade the hepatic impairment and tell me why the INR matters more than the ALT for dosing. [6]
Strong answer should include:
- Name the five Child-Pugh variables: bilirubin, albumin, INR, ascites, encephalopathy. [6]
- Score roughly 11 to 12, Child-Pugh class C (severe). [6]
- Explain the INR reflects hepatic synthetic function, which is what clears many drugs, whereas the ALT reflects injury not clearance. [6]
- Plan: reduce hepatically cleared maintenance doses by around half, prefer renally cleared antibiotics guided by the eGFR, avoid sedatives and NSAIDs. [5] [6]
Trap: treating a near-normal ALT as proof of preserved hepatic clearance, and missing failing synthetic function. [6]
Branch C — Vancomycin level
Examiner: A child on vancomycin every six hours for a central-line infection has a trough drawn one hour after the infusion of 22 mg per L. How do you interpret this and what do you do next? [7]
Strong answer should include:
- Recognise the timing is wrong: a trough is taken just before the next dose, so a level drawn one hour after the infusion is a post-peak value, not a trough, and is uninterpretable as a trough. [7]
- State the 2020 consensus preference for area-under-the-curve guided dosing targeting 400 to 600 mg per h per L for serious MRSA infection. [7]
- Order a correctly timed level before acting on the number, and check the creatinine trend. [7]
- Distinguish a rate-related infusion reaction from anaphylaxis if the child is also flushed. [7]
Trap: acting on a mistimed level and either over- or under-dosing the child. [7]
Branch D — Adolescent at transition
Examiner: A 17-year-old with stable CKD transfers to adult care. The paediatric Schwartz equation is in use. What should change at handover? [3]
Strong answer should include:
- Agree the estimating equation with the adult team to avoid a jump in the GFR estimate at handover. [3]
- Reconcile weight-capped adult doses with the paediatric weight-based doses. [5]
- Use a continuity equation such as the Full Age Spectrum creatinine equation across the transition. [3]
- Hand over the reason for any non-standard dose, the last levels, and the monitoring plan. [5]
Trap: carrying a paediatric equation and dose into adult care without confirming continuity, producing a silent dosing error. [3]
You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship atlas.
References6Show ledgerHide ledger
- [1]Schwartz GJ, et al New equations to estimate GFR in children with CKD J Am Soc Nephrol, 2009.PMID 19158356
- [4]Stevens PE, et al Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline Ann Intern Med, 2013.PMID 23732715
- [5]Verbeeck RK, et al Pharmacokinetics and dosage adjustment in patients with renal dysfunction Eur J Clin Pharmacol, 2009.PMID 19543887
- [6]Verbeeck RK, et al Effect of hepatic insufficiency on pharmacokinetics and drug dosing Pharm World Sci, 1998.PMID 9820880
- [7]Rybak MJ, et al Therapeutic monitoring of vancomycin for serious MRSA infections: a revised consensus guideline Am J Health Syst Pharm, 2020.PMID 32191793
- [3]Pottel H, et al Development and Validation of a Modified Full Age Spectrum Creatinine-Based Equation to Estimate Glomerular Filtration Rate Ann Intern Med, 2021.PMID 34280339